FIELD: pharmaceutics.
SUBSTANCE: the suggested hemostatic material contains collagen and thrombocytic mass dried due to freeze drying and structured in formaldehyde vapors, moreover, it contains transfusion-unsuitable thrombocytes at the following ratio: collagen : thrombocytes = 100:(0.5-2.5). Additionally, this material may contain antiseptics or antibiotics of wide spectrum of action. The innovation enables to apply thrombocytes after cryodestruction, and, also, transfusion-unsuitable thrombocytes (overdue storage period), that is apply the material which is considered to be useless. The material suggested is of high hemostatic activity.
EFFECT: higher efficiency of application.
11 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIMICROBIAL HAEMOSTATIC SPONGE | 2008 |
|
RU2396984C2 |
HEMOSTATIC SPONGE | 1996 |
|
RU2122867C1 |
METHOD OF COLLAGEN PLATES PREPARING | 1996 |
|
RU2118176C1 |
HAEMOSTATIC SPONGE | 2008 |
|
RU2385726C1 |
METHOD OF STERILE COLLAGEN BASE "FIBRICOLL" PREPARING | 1996 |
|
RU2118168C1 |
METHOD OF DETERMINING ADHESION OF THROMBOCYTES | 0 |
|
SU1734020A1 |
HEMOSTATIC SPONGE | 1992 |
|
RU2034572C1 |
METHOD OF PREPARING WOUND COVERING "DIGESTOL" | 1996 |
|
RU2127128C1 |
WOUND-HEALING COATING | 1994 |
|
RU2085217C1 |
OSTEOTROPIC MEMBRANE AND METHOD FOR PRODUCING THE OSTEOTROPIC MEMBRANE | 1999 |
|
RU2159100C1 |
Authors
Dates
2006-11-20—Published
2005-06-06—Filed